$ Value
$0
Shares
7,888
Price
$0
Filed
Jan 2
Insider
Name
KEATING LAURIE
Title
—
CIK
0001620743
Roles
Transaction Details
Transaction Date
2026-01-01
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
7,888
Footnotes
Pursuant to the Immuneering Corporation Non-Employee Director Compensation Program (the "Compensation Program"), the reporting person elected to receive this stock option in lieu of receiving the cash Base Retainer (as defined in the Compensation Program). | The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in the Compensation Program) following the grant date, such that the fourth and final installment will vest and become exercisable on the first anniversary of the grant date, subject in each case to such continuous service.
Filing Info
KEATING LAURIE's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-01 | IMRX | A | $0 |
| 2025-06-13 | IMRX | A | $0 |
| 2025-06-04 | PEPG | A | $0 |
Other Insiders at IMRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Matushansky Igor
Chief Medical Officer
|
— | — | 2026-02-03 |
|
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
|
— | — | 2026-02-03 |
|
Zeskind Benjamin J.
PRESIDENT AND CEO
|
— | — | 2026-02-03 |
|
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-02-03 |
|
Morales Mallory
SVP Finance, CAO
|
— | — | 2026-02-03 |
|
Neufeld Leah R
CHIEF PEOPLE OFFICER
|
— | — | 2026-03-13 |
|
Brakewood Harold Eugene
Chief Business Officer
|
— | — | 2026-02-03 |